Comparison of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable gastric banding

Medicina (Lithuania)

Volumn 49, Issue 1, 2013, Pages 9-14

  Urbanavičius, Vaidotas ^a   Abalikšta, Tomas ^a   Brimas, Gintautas ^a   Abraitiene, Agne ^a   Gogeliene, Laima ^a   Strupas, Kȩstutis ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Adiponectin; Laparoscopic adjustable gastric banding; Leptin

Indexed keywords

ADIPOCYTOKINE;

ADULT; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LAPAROSCOPY; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT REDUCTION;

ADIPOKINES; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROPLASTY; HUMANS; INSULIN RESISTANCE; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 84884264897     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina49010002     Document Type: Article

References (30)

1. Ardern CI, Janssen I, Ross R, Katzmarzyk PT. Development of health-related waist circumference thresholds within BMI categories. Obes Res 2004;12:1094-103.
2. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
3. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006;14 Suppl 5:242S-9S.
4. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
5. Reidy SP, Weber J. Leptin: an essential regulator of lipid metabolism. Comp Biochem Physiol A Mol Integr Physiol 2000;125:285-98.
6. Ruhl CE, Harris TB, Ding J, Goodpaster BH, Kanaya AM, Kritchevsky SB, et al. Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. Am J Clinical Nutrition 2007;85:1121-6.
7. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 2007;21:1443-55.
8. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti, Garancini MP, et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003;26:2883-9.
9. Hattori A, Uemura K, Miura H, Ueda M, Tamaya N, Iwata F, et al. Gender-related difference in relationship between insulin resistance and serum leptin level in Japanese type 2 diabetic and non-diabetic subjects. Endocr J 2000;47:615-21.
10. Hovso D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, et al. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocr 2009;161:451-8.
11. Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes Care 2008;31 Supp 2:S297-302.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7): 539-53.
14. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care 2009;32(11):2133-5.
15. Bult MJF, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol 2008;158:135-45.
16. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-52.
17. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity 2006;14(9):1553-61.
18. Hanusch-Enserer U, Cauza E, Brabant G, Dunky A, Rosen H, Pacini G, et al. Plasma ghrelin in obesity before and after weight loss after laparoscopic adjustable gastric banding. J Clin Endocrinol Metab 2004;89(7):3352-8.
19. Engl J, Bobbert T, Ciardi C, Laimer M, Tatarczyk T, Kaser S, et al. Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity 2007;15(5):1172-8.
20. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25(2):358-63.
21. Ryo M., Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975-81.
22. Yatagai T, Nagasaka S, Taniquchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003;52:1274-8.
23. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9.
24. Urbanavicius V, Abraitiene A, Vitkus D, Borovkiene R, Kucinskiene ZA. Adiponectin and insulin resistance in prediabetes and early type 2 diabetes mellitus. Gerontologija 2008;9(1):7-14.
25. Urbanavicius V, Abraitiene A, Vitkus D, Borovkiene R, Kucinskiene ZA. Adiponectin and uric acid in pre-diabetes and early type 2 diabetes mellitus. Acta Medica Lituanica 2008;15(2):81-7.
26. Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, et al. Leptin and body fat in type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab 2003;88: 1543-53.
27. Diker D, Vishne T, Maayan R, Weizman A, Vardi P, Dreznik Z, et al. Impact of gastric banding on plasma adiponectin levels. Obes Surg 2006;16(8):1057-61.
28. Shak JR, Roper J, Perez-Perez GI, Tseng CH, Francois F, Gamagaris Z, et al. The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg 2008;18(9):1089-96.
29. Gonzalez-Sanchez JL, Zabena CA, Martínez-Larrad MT, Fernandez-Perez C, Perez-Barba M, Laasko M, et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 2005;13:807-12.
30. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004;53:585-90.